RxDoctor Payments Data

Melissa Morlote Triana, PA

Physician Assistant · Davie, FLNPI 1275095051

Payments from drug & device makers

$2,028in general payments, 2019–2025

Across 39 payments — averaging $51.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1K
  • E.r. Squibb & Sons, L.L.C.$149
  • Boston Scientific$127
  • Philips North America LLC$121
  • Johnson & Johnson$66
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$45
  • plus $143 from 6 others

What the payments were for

  • Travel & lodging$82941%
  • Food & beverage$1,19759%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,028 in reported general payments places this provider in the 75th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$24,885
Medicare patients
116
Services billed
361

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin58$49,698
EliquisApixaban51$40,067
OzempicSemaglutide11$10,736
Ranolazine ErRanolazine24$1,753
Rosuvastatin Calcium59$1,464
Atorvastatin Calcium50$740
Losartan Potassium60$699
Metoprolol Succinate68$688
Spironolactone65$604
Valsartan16$384
Carvedilol33$266
Lisinopril24$232
Amlodipine Besylate23$158
Clonidine Hcl11$55
Furosemide19$27

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$23$49,69858 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Davie

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →